Global Medical REIT Inc. (NYSE:GMRE) Short Interest Update

Global Medical REIT Inc. (NYSE:GMRE) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 1,140,000 shares, a growth of 8.6% from the December 15th total of 1,050,000 shares. Based on an average daily trading volume, of 444,500 shares, the short-interest ratio is presently 2.6 days.

Global Medical REIT Stock Down 1.8 %

Shares of NYSE GMRE opened at $7.97 on Tuesday. Global Medical REIT has a 1 year low of $7.33 and a 1 year high of $10.58. The company has a market capitalization of $532.69 million, a P/E ratio of -398.50, a P/E/G ratio of 1.22 and a beta of 1.23. The company has a 50 day simple moving average of $8.25 and a 200-day simple moving average of $8.99. The company has a debt-to-equity ratio of 1.26, a current ratio of 0.28 and a quick ratio of 0.28.

Global Medical REIT (NYSE:GMRE) last posted its earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.18). Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. The business had revenue of $34.26 million for the quarter, compared to analyst estimates of $34.88 million. During the same period last year, the business earned $0.23 EPS. On average, equities research analysts predict that Global Medical REIT will post 0.81 earnings per share for the current year.

Global Medical REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 8th. Investors of record on Friday, December 20th were issued a $0.21 dividend. The ex-dividend date of this dividend was Friday, December 20th. This represents a $0.84 annualized dividend and a yield of 10.53%. Global Medical REIT’s dividend payout ratio (DPR) is currently -4,200.00%.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. JPMorgan Chase & Co. raised its stake in shares of Global Medical REIT by 54.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 231,927 shares of the company’s stock valued at $2,298,000 after acquiring an additional 81,596 shares during the period. Franklin Resources Inc. raised its position in Global Medical REIT by 228.9% in the third quarter. Franklin Resources Inc. now owns 114,988 shares of the company’s stock valued at $1,073,000 after purchasing an additional 80,030 shares during the period. AQR Capital Management LLC lifted its stake in Global Medical REIT by 71.1% during the second quarter. AQR Capital Management LLC now owns 188,931 shares of the company’s stock worth $1,715,000 after purchasing an additional 78,528 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Global Medical REIT by 158.6% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 120,614 shares of the company’s stock worth $1,195,000 after buying an additional 73,965 shares during the period. Finally, Barclays PLC grew its stake in shares of Global Medical REIT by 87.1% in the third quarter. Barclays PLC now owns 154,051 shares of the company’s stock valued at $1,527,000 after buying an additional 71,704 shares in the last quarter. Hedge funds and other institutional investors own 57.52% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank assumed coverage on Global Medical REIT in a research note on Friday, October 18th. They issued a “buy” rating and a $11.75 target price for the company.

Global Medical REIT Company Profile

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.